Mainline Biosciences (shanghai) Co., Ltd

This study tests a new drug called MB0151 in adults with advanced solid tumors, including certain lung, breast, and neuroendocrine cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow their grow…